Abstract
Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents. © 2013 by Lippincott Williams & Wilkins.
Author supplied keywords
Cite
CITATION STYLE
Davarpanah, A. H., & Weinreb, J. C. (2013). The role of imaging in hepatocellular carcinoma: The present and future. In Journal of Clinical Gastroenterology (Vol. 47). https://doi.org/10.1097/MCG.0b013e31827f0d3d
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.